Active ingredient
Benralizumab
3 finished FDA listings contain Benralizumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- BENRALIZUMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 10 mg/.5ml · 30 mg/ml
- Brand names in FDA listings
- Fasenra
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1989100
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761070 | ASTRAZENECA AB | 2017-11-14 | 3 |
Official labeling on DailyMed
- FASENRA (BENRALIZUMAB) INJECTION, SOLUTION [ASTRAZENECA PHARMACEUTICALS LP] · version 27 · 2026-05-28
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.